You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《港股》恆指半日跌242點 科技股回落 醫藥股續受捧
科技股回吐拖累港股早市下跌,恆指低開107點後跌幅擴大,曾跌309點低見25,252點,半日跌242點或0.9%,報25,319點;國指跌108點或1.2%,報9,068點;恆生科技指數跌99點或1.8%,報5,564點。大市半日成交總額1,424.06億元。 科技股方面,阿里(09988.HK)及騰訊(00700.HK)跌1.2%,京東(09618.HK)及美團(03690.HK)跌1.7%,快手(01024.HK))、百度(09888.HK)、網易(09999.HK)及嗶哩嗶哩(09626.HK)跌2.1%至3%,中芯(00981.HK)跌1.5%。此外,商湯(00020.HK)及金山雲(03896.HK)跌3.7%及5.9%,美圖(01357.HK)升5.2%。 報道指小米首款AI眼鏡由雷軍親自拍板立項,目標三年內年出貨量逾五百萬副,小米(01810.HK)吐3.8%。電訊設備股中興(00763.HK)溢價15.9%發可轉債料淨籌逾35億人幣,股價跌4.2%。車股方面,吉利(00175.HK)及比亞迪(01211.HK)跌1.2%及1.6%,蔚來(09866.HK)跌3%。小鵬否認年內整合產品線減產,小鵬(09868.HK)跌1.6%。 藥明康德(02359.HK)中期純利增96%每10股派息3.5元,上調全年收入指引,股價升10.3%,同系藥明生物(02269.HK)升3.8%,藥明巨諾(02126.HK)炒高逾25%。其他醫藥股普遍上漲,綠葉(02186.HK)升8%,康龍化成(03759.HK)及石藥(01093.HK)升6.2%,三生製藥(01530.HK)升5.2%,信達生物(01801.HK)升4.4%,恆瑞醫藥(01276.HK)半日回吐3%。 內地育兒補貼落地,3歲以下嬰幼兒每孩每年3,600元人幣,錦欣生殖(01951.HK)高開8.9%,半日倒跌1.2%,奶粉股中國飛鶴(06186.HK)高開5.1%,半日倒跌0.6%。 其他股份方面,匯控(00005.HK)跌0.5%,港交所(00388.HK)跌2.4%,友邦(01299.HK)升0.4%。衆安在線(06060.HK)跌4.1%。國泰君安國際(01788.HK)跌1%,成交逾20億元。老鋪黃金(06181.HK)及泡泡瑪特(09992.HK)升2.3%及2.5%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account